Aspartame

Aspartame

SCHEMBL216238

COC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](N)CC(=O)O

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.64
THRB P10828 1/20 0.64
CYP2C9 P11712 1/20 0.64
CYP2C19 P33261 1/20 0.64
HSD17B10 Q99714 1/20 0.64
OPRK1 P41145 1/20 0.58
ATM Q13315 2/20 0.58
POLB P06746 1/20 0.55
BIRC2 Q13490 1/20 0.54
LMNA P02545 1/20 0.53
GLA P06280 1/20 0.53
TSHR P16473 1/20 0.53
ANPEP P15144 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aspartame SCHEMBL19283498 1.00 ALDH1A1 (0.64) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
Aspartame SCHEMBL10625481 1.00 ALDH1A1 (0.64) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
Aspartame SCHEMBL28591 1.00 ALDH1A1 (0.64) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
Aspartame SCHEMBL900809 1.00 ALDH1A1 (0.64) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
Aspartame SCHEMBL3637 1.00 ALDH1A1 (0.64) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
Aspartame SCHEMBL10635593 1.00 ALDH1A1 (0.64) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
Aspartame SCHEMBL11085391 1.00 ALDH1A1 (0.64) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
Aspartame SCHEMBL8091203 1.00 ALDH1A1 (0.64) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
Aspartame SCHEMBL8761655 1.00 ALDH1A1 (0.64) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
Aspartame SCHEMBL3636 1.00 ALDH1A1 (0.64) ALDH1A1THRBCYP2C9CYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1685 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11241397-B2 Continuous local slow-release of therapeutics for head and neck problems and upper aerodigestive disorders UNIV LOUISIANA STATE (US) 2022-02-08 US claimed
US-20200289432-A1 CONTINUOUS LOCAL SLOW-RELEASE OF THERAPEUTICS FOR HEAD AND NECK PROBLEMS AND UPPER AERODIGESTIVE DISORDERS UNIV LOUISIANA STATE (US) 2020-09-17 US claimed
US-20160051492-A1 CONTINUOUS LOCAL SLOW-RELEASE OF THERAPEUTICS FOR HEAD AND NECK PROBLEMS AND UPPER AERODIGESTIVE DISORDERS BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2016-02-25 US claimed
US-8308479-B2 Method and apparatus for tooth whitening DENTOVATIONS INC. (US) 2012-11-13 US claimed
US-20090148815-A1 Method and apparatus for tooth whitening FRENCH TRANSIT, LLC 2009-06-11 US claimed
EP-1633270-A4 METHOD AND APPARATUS FOR TOOTH WHITENING DENTOVATIONS INC (US) 2009-04-29 EP claimed
EP-1575551-A4 NUTRITIONAL SUPPLEMENT COMPOSITION AND METHOD GEL DYNAMICS LLC (US) 2006-12-27 EP claimed
US-20060141422-A1 Method and apparatus for tooth whitening DENTOVATIONS INC. 2006-06-29 US claimed
CN-1784216-A Nutritional supplement composition and method GEL DYNAMICS LLC (US) 2006-06-07 CN claimed
EP-1633270-A1 METHOD AND APPARATUS FOR TOOTH WHITENING Dentovations Inc. (US) 2006-03-15 EP claimed
EP-1575551-A1 NUTRITIONAL SUPPLEMENT COMPOSITION AND METHOD Gel Dynamics, llc (US) 2005-09-21 EP claimed
US-20050112177-A1 Nutritional supplement composition and method DOPSON MINTER H (US) 2005-05-26 US claimed
WO-2004108003-A1 METHOD AND APPARATUS FOR TOOTH WHITENING DENTOVATIONS INC. (US) 2004-12-16 WO claimed
WO-2004060342-A1 NUTRITIONAL SUPPLEMENT COMPOSITION AND METHOD GEL DYNAMICS, LLC (US) 2004-07-22 WO claimed
CN-1066765-A MICROENCAPSULATED SWEETENERS FOR USE IN BAKED GOODS REDDING BRUCE K (US) 1992-12-09 CN claimed
WO-1992011084-A1 MICROENCAPSULATED SWEETENERS FOR USE IN BAKED GOODS REDDING BRUCE K JR (US) 1992-07-09 WO claimed
JP-4230299-A None JP disclosed
WO-2026089752-A1 COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES Finitus, LLC (US) 2026-04-30 WO disclosed
WO-1987003617-A1 MODULATION OF ANIMAL CELLULAR RESPONSES WITH COMPOSITIONS CONTAINING ISOXANTHOPTERIN-8-(1'-BETA-ALDOGLYCOSIDYL) DERIVATIVES SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) 1987-06-18 WO disclosed
EP-0212972-A2 Bioconversion process ALLELIX INC. (CA) 1987-03-04 EP disclosed